[1]孙康文,罗 刚.甲氨蝶呤联合阿达木单抗治疗早期类风湿性关节炎患者的效果及对血清CD206含量的影响[J].医学信息,2020,33(23):141-143.[doi:10.3969/j.issn.1006-1959.2020.23.041]
　SUN Kang-wen,LUO Gang.The Effect of Methotrexate Combined with Adalimumab in the Treatment of Patients with Early Rheumatoid Arthritis and Its Effect on Serum CD206 Levels[J].Medical Information,2020,33(23):141-143.[doi:10.3969/j.issn.1006-1959.2020.23.041]
点击复制

甲氨蝶呤联合阿达木单抗治疗早期类风湿性关节炎患者的效果及对血清CD206含量的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
33卷
期数:
2020年23期
页码:
141-143
栏目:
药物与临床
出版日期:
2020-12-01

文章信息/Info

Title:
The Effect of Methotrexate Combined with Adalimumab in the Treatment of Patients with Early Rheumatoid Arthritis and Its Effect on Serum CD206 Levels
文章编号:
1006-1959（2020）23-0141-03
作者:
孙康文; 罗 刚
（重庆医科大学附属第一医院骨科，重庆 400016）
Author(s):
SUN Kang-wen; LUO Gang
(Department of Orthopedics,the First Affiliated Hospital of Chongqing Medical University,Chongqing 400016,China)
关键词:
类风湿性关节炎; 抗肿瘤坏死因子α; CD206
Keywords:
Rheumatoid arthritis; Anti-tumor necrosis factor α; CD206
分类号:
R593.22
DOI:
10.3969/j.issn.1006-1959.2020.23.041
文献标志码:
A
摘要:
目的 分析甲氨蝶呤联合阿达木单抗治疗早期类风湿性关节炎患者的效果及对血清CD206含量的影响。方法 选取2015年6月~2019年6月我院治疗的150例早期类风湿性关节炎患者作为研究对象，按照随机数字表法分为研究组和对照组，每组75例。对照组予以甲氨蝶呤和安慰剂治疗，研究组予以甲氨蝶呤联合阿达木单抗治疗，比较两组用药前、用药后3、6、12、24个月血清CD206表达水平及类风湿性关节炎病情变化情况。结果 治疗后6、12、24个月，研究组CD206含量低于对照组，差异有统计学意义（P＜0.05）。研究组关节腔内注射糖皮质激素次数为（9.62±4.23）次，与对照组的（9.77±4.28）次比较，差异无统计学意义（P＞0.05）。两组治疗后3个月CRP、关节肿痛数及VAS评分较治疗前降低，差异有统计学意义（P＜0.05）；但组间比较，差异无统计学意义（P＞0.05）；两组治疗后6、12个月CRP、关节肿痛数及VAS评分较治疗前降低，且研究组低于对照组，差异有统计学意义（P＜0.05）。结论 甲氨蝶呤联合阿达木单抗治疗能降低早期类风湿性关节炎患者CD206水平及疾病活动指数，缓解患者疼痛症状。
Abstract:
Objective To analyze the effect of methotrexate combined with adalimumab in the treatment of patients with early rheumatoid arthritis and its influence on serum CD206 levels.Methods The study included 150 patients with early rheumatoid arthritis who accepted treatment in our hospital from June 2015 to June 2019, and they were divided into study group(75 cases) and control group(75 cases) , randomly. Patients in study group were treated with methotrexate and atamuzumab, and the patients in control group were treated with methotrexate and placebo. Serum CD206 levels and rheumatoid arthritis activity were compared between the two groups before and after medication at 3, 6, 12 and 24 months.Results At 6, 12, and 24 months after treatment, the CD206 content of the study group was lower than that of the control group,the difference was statistically significant (P<0.05). The number of intra-articular injections of glucocorticoids in the study group was (9.62±4.23) times, compared with (9.77±4.28) times in the control group, the difference was not statistically significant (P>0.05). 3 months after treatment, CRP,joint swelling and pain, and VAS score were lower in the two groups than before treatment,the difference was statistically significant (P<0.05); but there was no statistically significant difference between the two groups (P>0.05); At 6 and 12 months after treatment, CRP, joint swelling and pain, and VAS score were lower than before treatment, and the study group was lower than the control group, the difference was statistically significant (P<0.05).Conclusion The treatment of methotrexate combined with adalimumab can reduce the CD206 level and disease activity index of patients with early rheumatoid arthritis, and relieve the pain symptoms of patients.

参考文献/References:

[1]Zhang Q,Liu Q,Lin C,et al.The prevalence of rheumatoid arthritis in middle-aged and elderly people living in Naqu City,Tibet,Autonomous Region of China[J].J Orthop Surg Res,2020,15(1):338. [2]McInnes IB,Schett G.Pathogenetic insights from the treatment of rheumatoid arthritis[J].Lancet,2017,389(10086):2328-2337. [3]Markusse IM,Akdemir G,Dirven L,et al.Long-term outcomes of patients with recent-onset rheumatoid arthritis after 10 years of tight controlled treatment.A randomized trial[J].Ann Intern Med,2016,164(8):523-531. [4]Garcia-Aguilar T,Espinosa-Cueto P,Magallanes-Puebla A,et al.The Mannose Receptor Is Involved in the Phagocytosis of Mycobacteria-Induced Apoptotic Cells[J].J Immunol Res,2016(2016):3845247. [5]Jordens R,Thompson A,Amons R,et al.Human dendritic cells shed a functional,soluble form of the mannose receptor[J].Int Immunol,1999,11(11):1775-1780. [6]赵金霞,刘湘源,苏茵,等.早期类风湿关节炎分类标准及2010年ACR/EULAR分类标准在早期RA中诊断价值的比较[C]//第17次全国风湿病学学术会议中华医学会会议论文集,2012. [7]Horslev-Petersen K,Hetland ML,Junker P,et al.Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates,function and quality of life.The OPERA study:an investigator-initiated,randomised,double-blind,parallel-group,placebo-controlled trial[J].Ann Rheum Dis,2014,73(4):654-661. [8]Nielsen MC,Hvidbjerg Gantzel R,Clària J,et al.Macrophage Activation Markers, CD163 and CD206,in Acute-on-Chronic Liver Failure[J].Cells,2020,9(5):1175. [9]Li X,Li ZG.APLAR recommendations for treatments of rheamatoid arthritis in 2015[J].Chin J Rheumatol,2016,20(4):286-288. [10]von Richter O,Lemke L,Haliduola H,et al.GP2017, an adalimumab biosimilar: pharmacokinetic similarity to its reference medicine and pharmacokinetics comparison of different administration methods[J].Expert Opin Biol Ther,2019,19(10):1075-1083. [11]Lurati AM,Laria A,Marrazza M,et al.The macrophages in rheumatic diseases[J].J Inflamm Res,2016(9):1-11. [12]Cope FO,Abbruzzese B,Sanders J,et al.The inextricable axis of targeted diagnostic imaging and therapy:an immunological natural history approach[J].Nucl Med Biol,2016,43(12):215-225.

相似文献/References:

[1]徐凯捷,欧阳桂林.加味八珍汤治疗类风湿性关节炎膝关节置换术后贫血的疗效[J].医学信息,2020,33(04):165.[doi:10.3969/j.issn.1006-1959.2020.04.055]
　XU Kai-jie,OUYANG Gui-lin.Effect of Jiawei Bazhen Decoction on Anemia after Rheumatoid Arthritis Knee Replacement[J].Medical Information,2020,33(23):165.[doi:10.3969/j.issn.1006-1959.2020.04.055]
[2]沈微.类风湿关节炎并血白细胞减少症转化急性白血病1例及文献复习[J].医学信息,2020,33(08):189.[doi:10.3969/j.issn.1006-1959.2020.08.065]
[3]孙 杰,李 洋,温大蔚,等.类风湿性关节炎关节皮肤温度与疾病活动度的关系[J].医学信息,2020,33(12):80.[doi:10.3969/j.issn.1006-1959.2020.12.023]
　SUN Jie,LI Yang,WEN Da-wei,et al.Relationship Between Joint Skin Temperature and Disease Activity in Rheumatoid Arthritis[J].Medical Information,2020,33(23):80.[doi:10.3969/j.issn.1006-1959.2020.12.023]
[4]陈朴阳,刘 涛,范凯健.类风湿性关节炎的生物标志物及其测定[J].医学信息,2020,33(15):37.[doi:10.3969/j.issn.1006-1959.2020.15.013]
　CHEN Pu-yang,LIU Tao,FAN Kai-jian.Biomarkers of Rheumatoid Arthritis and Their Determination[J].Medical Information,2020,33(23):37.[doi:10.3969/j.issn.1006-1959.2020.15.013]
[5]车 宇.滑膜切除结合Kapandji手术治疗腕类风湿性关节炎并伸肌腱断裂、尺骨小头脱位的效果[J].医学信息,2020,33(23):183.[doi:10.3969/j.issn.1006-1959.2020.23.056]
　CHE Yu.Synovectomy Combined with Kapandji Operation in the Treatment of Wrist Rheumatoid Arthritis with Extensor Tendon Rupture and Dislocation of the Ulnar Head[J].Medical Information,2020,33(23):183.[doi:10.3969/j.issn.1006-1959.2020.23.056]
[6]廖锋生.硫酸羟氯喹治疗类风湿性关节炎的疗效及对患者炎症因子、自身抗体水平的影响[J].医学信息,2023,36(08):151.[doi:10.3969/j.issn.1006-1959.2023.08.033]
　LIAO Feng-sheng.Efficacy of Hydroxychloroquine Sulfate in the Treatment of Rheumatoid Arthritis and its Effect on the Levels of Inflammatory Factors and Autoantibodies[J].Medical Information,2023,36(23):151.[doi:10.3969/j.issn.1006-1959.2023.08.033]
[7]李爱丽,赵中亭,张学梅,等.多普勒超声在RA早期小关节损伤中的应用[J].医学信息,2022,35(01):39.[doi:10.3969/j.issn.1006-1959.2022.01.009]
　LI Ai-li,ZHAO Zhong-ting,ZHANG Xue-mei,et al.Application of Doppler Ultrasonography in Early Facet Joint Injury of RA[J].Medical Information,2022,35(23):39.[doi:10.3969/j.issn.1006-1959.2022.01.009]
[8]岑村红,何 吉,支太发,等.基于网络药理学探究脊蛇祛湿胶囊君药金毛狗脊治疗RA的作用机制[J].医学信息,2023,36(13):1.[doi:10.3969/j.issn.1006-1959.2023.13.001]
　CEN Cun-hong,HE Ji,ZHI Tai-fa,et al.The Mechanism of Action of the Cibotium Barometz of Jishe Qushi Capsule in the Treatment of RA Based on Network Pharmacology[J].Medical Information,2023,36(23):1.[doi:10.3969/j.issn.1006-1959.2023.13.001]
[9]邹 滔,谢湘雄,禹勇军,等.三痹颗粒治疗类风湿性关节炎的临床观察及网络药理学研究[J].医学信息,2024,37(04):14.[doi:10.3969/j.issn.1006-1959.2024.04.003]
　ZOU Tao,XIE Xiang-xiong,YU Yong-jun,et al.Clinical Observation and Network Pharmacology Study on the Treatment of Rheumatoid Arthritis with Sanbi Granule[J].Medical Information,2024,37(23):14.[doi:10.3969/j.issn.1006-1959.2024.04.003]

更新日期/Last Update: 1900-01-01